Home / Going-concern warnings / Latigo Biotherapeutics, Inc.
Filed 2026-09-03 路 Form 10-Q 路 Accession 0001193125-26-381969 small
Price before filing: $21.77 (2026-09-02 close, split/dividend-adjusted)
Market cap at flag: $1.35B (2026-09-03) 路 Latest: $928.2M (2026-10-16)
| Window | LTGO | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -23.6% | +1.5% | -25.1% | 2026-10-05 |
| 90 days | pending | pending | until 2026-12-02 | |
| 180 days | pending | pending | until 2027-03-02 | |
| 1 year | pending | pending | until 2027-09-03 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 2 insiders bought $5.0M (2 purchases)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Foresite Capital Management V, LLC (+5 joint filers) 10% owner | Purchase | 140,000 | $18.00 | $2.5M | no | Form 4 |
| 2026-08-10 | Tananbaum James B. Director, 10% owner | Purchase | 140,000 | $18.00 | $2.5M | no | Form 4 |
| 2026-09-03: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-06-05 to 2026-10-03. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated. 2."
Quoted from the filing. Source
Going-concern doubt disclosed, then alleviated: the company said conditions raised substantial doubt about its ability to continue as a going concern, but that its plans or new funding resolve that doubt for the next 12 months. A weaker warning than an unresolved going-concern doubt, but the company recently needed a rescue plan or fresh money to stay afloat.
Source: management disclosure in Form 10-Q (period 2026-06-30)
Status: doubt alleviated (the company says its plans or new funding resolve the substantial doubt it disclosed)
Why this score: substantial doubt disclosed, then alleviated by management's plans or new funding; quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.